Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Freegold Intersects 2.72 g/t Au over 139.9 metres at Golden Summit (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Agile Therapeutics Equity Warrants
AGXRW
Agile Therapeutics, Inc. is a women's healthcare company, which is engaged in fulfilling the unmet health needs of women. Its product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Its initial product, Twirla, (levonorgestrel and ethinyl estradiol), a transdermal system...
, is a non-daily prescription contraceptive. Twirla is based on its proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Twirla (levonorgestrel and ethinyl estradiol) transdermal system is a once-weekly combined hormonal contraceptive (CHC) patch that contains the active ingredients levonorgestrel (LNG), a type of progestin, and ethinyl estradiol (EE), a type of estrogen. Its potential product pipeline consists of two types of product candidates: a progestin-only (P-only) contraceptive patch and potential Twirla line extensions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:AGXRW)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
Next
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 18, 2023 1:59pm
AGRX....sub $2 and dropping
Oh well ....back to the Drawing board Cheers
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 17, 2023 11:22am
AGRX....a past pick of mine
This did perform after my buy recommendation....only problem was that all the action was during After Hours trading when it doubled......opened the following morning higher but not as highthen ended
...more
Benton Intersects 22.0 m Grading 7.47% Copper Including 8.0 m Grading 11.93%
posted Jan 21, 2025 9:00am by
Benton Resources Inc.
-
|
Grades and widths of this calibre are exceptionally rare in our industry. Confirming gold and copper mineralization in a parallel zone that is associated with an unsourced strong conductor has our team extremely excited ...read more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 15, 2023 12:11pm
AGRX....She just keeps bleeding...slowly as it is.
Sub $2 ....only a few cents away. How low can this go? All those promises and the $12 target.....sorry but it's not working Cheers !
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 13, 2023 10:35am
AGRX.....your all talk and no action
As previously mentioned......Lights are on but nobody's home No to low volume I believe this to be heading South for the winter Sub $2 for sure Cheers !
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 05, 2023 8:05am
New Press Release - Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
PRINCETON, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairperson and Chief Executive Officer Al Altomari and Chief Commercial Officer Amy Welsh will present at the H.C. Wainwright 25th Annual Global...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 01, 2023 10:33am
AGRX....this p.o.s. could never hold a gain
Low volume as usual with all the "Frontloaders" offing their paper Happy Fryday !
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 17, 2023 10:24am
AGRX....Money talks.....Bull Feces walks
Keep making your promises with no delivery Go Chit in a River !!!! Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 17, 2023 9:02am
New Press Release - Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
PRINCETON, NJ / ACCESSWIRE / August 17, 2023 / On August 9, Agile Therapeutics (NASDAQ:AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative weekly birth control patch, Twirla® (levonorgestrel and ethinyl estradiol), and a widening gross...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 14, 2023 1:51pm
AGRX ...... makes sure you're all "lubed up".....
Here comes the "Royal Shaft".....sub $2 Wait for it
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 10, 2023 12:41pm
AGRX...this is absolutely comical
All Bull fecal matter
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 09, 2023 11:53am
AGRX......just the facts Jack !!!!!!!!!!!
ER states that a/o June 2023 theres ~ 1.7 million shares o/s..... I'd say theres more like 2.7 million. ER was good ....REV increase.....top & bottom line way better Cash burn was more but
...more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 09, 2023 11:26am
AGRX...Sorry Mr. Maggot..U better takes this a lot lower
Not leaving So go Chit in a river ; )
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 09, 2023 11:06am
AGRX....did u read the ER this a.m.....
Good news hits hard....no support Mr. M.....you're a real Maddapakka I say BS
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 09, 2023 8:05am
New Press Release - Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Twirla Delivers Second Quarter 2023 Net Revenue of $5.5 Million, a 44% Increase from First Quarter 2023Twirla Demand and Factory Sales Up 24% and 42% Respectively in Second Quarter 2023 Compared to First Quarter 2023Gross Margin Grows to 58% in Second Quarter 2023 from 47% in First Quarter 2023...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Aug 01, 2023 2:21pm
AGRX..... There it is again....tapping the ST DTL ; )
Still thin volume.....but if this gets a tailwind......it's gone to the moon. JMHO
Prev
1
2
3
4
5
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Eminent's First Drill Hole Hits Significant Gold-Arsenic in Getchell Trend Analogue and Second Hole Drilling Commences
U.S. DOD Logistics Agency Highlights V.GPH Project to Develop Eco-Friendly Graphite-Based Fire-Fighting Material
Alphamin Announces Record Fy2024 & Q4 2024 Tin Production Fy2025 Production Guidance Exploration Success
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.
BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*